EXL (NASDAQ:EXLS), a leading operations management and analytics company, today announced that it has signed a definitive agreement to acquire SCIOInspire®Holdings, Inc. (SCIO®), a West Hartford Connecticut-based leading healthcare analytics solution and services company (doing business as SCIO Health Analytics).
Rohit Kapoor, EXL Vice Chairman and Chief Executive Officer stated, “The acquisition will strengthen EXL’s capability in the high growth cost optimization and care optimization markets. SCIO’s analytical tools and expertise in healthcare claims payment and care optimization expands EXL’s market-leading advanced analytics and healthcare capabilities. Combining the talented team at SCIO to our team of 2,000+ clinicians and 3,000+ data scientists worldwide significantly increases our ability to scale to meet the needs of larger clients and increases our reach into pharmacy benefit managers, healthcare providers and life sciences companies.”
“SCIO is dedicated to driving positive change by helping our clients effectively manage the transition to value-based care,” said Siva Namasivayam, Founder and Chief Executive Officer, SCIO. “We are excited to join EXL, a world-class operations management and analytics Company and a recognized leader in healthcare analytics. Together, our combined synergies and innovation in end-to-end cost recovery, care management and population risk management delivers powerful solutions to our clients – helping healthcare organizations achieve optimal outcomes while reducing the total cost of care.”
For more than 10 years SCIO has been driving care and reimbursement optimization for its clients through its leading healthcare analytics solutions and services. SCIO’s unique 360° view of the patient, provider and claim is informed by deep clinical, payment, analytics and data expertise. Through the use of integrated healthcare data, proprietary analytics, innovative technologies and flexible delivery methodologies, SCIO transforms data into actionable insights and proven outcomes. SCIO’s significant early investors include Sequoia India, Health Enterprise Partners and Saama Capital.
The aggregate merger consideration is $240 million, subject to adjustment based on, among other things, SCIO’s cash, debt, working capital position and other adjustments set forth in the Merger Agreement. EXL intends to fund the purchase with available cash on hand and borrowing from its credit facility. The acquisition is anticipated to close in the next three months, subject to the fulfillment of certain closing conditions, including regulatory and other customary consents.
TripleTree, LLC served as the exclusive strategic and financial advisor to SCIO in the transaction.